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Abstract
Pathogenic life styles can lead to highly specialized interactions with host species, potentially resulting in fitness trade-offs
in other ecological contexts. Here we studied how adaptation of the environmentally transmitted bacterial pathogen,
Pseudomonas aeruginosa, to cystic fibrosis (CF) patients affects its survival in the presence of natural phage (14/1, WKZ, PNM
and PT7) and protist (Tetrahymena thermophila and Acanthamoebae polyphaga) enemies. We found that most of the
bacteria isolated from relatively recently intermittently colonised patients (1–25 months), were innately phage-resistant and
highly toxic for protists. In contrast, bacteria isolated from long time chronically infected patients (2–23 years), were less
efficient in both resisting phages and killing protists. Moreover, chronic isolates showed reduced killing of wax moth larvae
(Galleria mellonella) probably due to weaker in vitro growth and protease expression. These results suggest that P.
aeruginosa long-term adaptation to CF-lungs could trade off with its survival in aquatic environmental reservoirs in the
presence of microbial enemies, while lowered virulence could reduce pathogen opportunities to infect insect vectors;
factors that are both likely to result in poorer environmental transmission. From an applied perspective, phage therapy
could be useful against chronic P. aeruginosa lung infections that are often characterized by multidrug resistance: chronic
isolates were least resistant to phages and their poor growth will likely slow down the emergence of beneficial resistance
mutations.
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Introduction
Parasitic lifestyles often demand complex adaptations to
circumvent host defences [1–3]. As a result, host-parasite
coevolutionary arms races are likely to promote specialization in
parasitic organisms [3,4]. Intracellular bacterial pathogens are one
extreme case of parasite specialization. For example, the small
genomes of Mycoplasma and Rickettsia are thought to arise as a result
of evolutionary transition from free-living environmental bacteria
to more permanent, pathogenic associate of its host species [5,6].
Commonly lost properties include genes related to bacterial energy
metabolism and amino acid synthesis: traits that become non-vital
for pathogen survival because the host can provide a surplus of
nutrients [6]. Moreover, immune evasion may be partly respon-
sible for loss of important virulence genes [7–9]. Interestingly,
similar loss of genes and functions has also been observed with
facultative, environmentally transmitted opportunistic pathogens
[8,10–12], which are continuously released from infected hosts to
external environment before being picked up by new hosts (e.g., in
sputum or faeces of cystic fibrosis (CF) and cholera patients,
respectively). While there has been considerable research into the
consequences of within-host adaptation for pathogen virulence,
[8,10–12], the impact of within-host specialisation on the
opportunistic pathogen survival in external environments is less
clear.
Many environmentally transmitted opportunistic pathogens are
generalists in the sense that many traits confer fitness advantages
both inside and outside the host (dual-use traits), and hence
adaptation to one environment may indirectly increase fitness in
the other [13,14]. Many studies have shown positive correlation
between virulence and survival in environmental reservoirs. For
example, resistance against degradative enzymes of amoeba can
help bacteria to resist attack by mammalian macrophages [15–17],
while proteases responsible for damaging host tissues often have
nutritional role in external environments [13]. This is, however,
not always the case and some pathogens can experience conflicting
selection pressures between external and internal environments
[18–20], where adaptation to one environment leads to reduced
fitness in the other [21,22]. As a result, adaptation to within-host
environments could reduce pathogen survival in external envi-
ronments through trade-offs or vice versa.
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Here we investigated these hypotheses by comparing the
survival and resistance of 28 P. aeruginosa strains isolated from
the lungs of CF patients (Table 1) to different natural protist
(Tetrahymena thermophila and Acanthamoebae polyphaga, Table 2) and
phage enemies (14/1, WKZ, PNM and PT7, Table 2). P. aeruginosa
is a good example of an environmentally transmitted, opportunis-
tic bacterial pathogen with broad host spectrum [23] and currently
about 10% of hospital-acquired infections in the European Union
hospitals are caused by P. aeruginosa [11], where the bacterium
often establishes itself in already compromised patients, such as
those with CF or hospitalized in intensive care units [11,12].
Recent studies involving whole-genome analysis have demonstrat-
ed that P. aeruginosa adaptation to human lung environment leads
to drastic changes including reduced growth, lowered motility,
down regulation of sigma factors, increased biofilm formation, loss
of quorum-sensing [8,10,12]. While most of these factors are
important for bacterial anti-predatory defences [15,24], they can
also affect the P. aeruginosa virulence [8,10,12,25,26].
Bacteria were categorised in two classes according to the
duration of infection: isolates from relatively short-term, intermit-
tent colonisations (1–25 months), and isolates from much older
chronic infection (2–23 years). This classification is based on the
following differences: strains from intermittent colonisations can be
eradicated with antibiotics and no antibodies are yet found from
patient serum, while in chronic infections, pathogens are
discovered continuously from sputum samples for .6 months
and/or there is a significant antibody response against P. aeruginosa
[27]. We used isolates from 7 intermittently colonised and 6
chronically infected patients. When patients had been sampled
repeatedly at different time points, patient mean values were used.
Differences in bacterial resistance against natural enemies were
measured in short-term growth assays in the absence and presence
of all different enemy species. Bacterial virulence was measured in
vivo in wax moth host, and a few potential virulence traits (motility,
biofilm formation, protease expression) were quantified with
standard microbiological assays.
Our results show that bacteria isolated from chronic infections
are more susceptible to both phage and protist predation and less
virulent in wax moth compared to bacteria isolated from
intermittent colonisations. These results complement a recent
study reporting less resistance to phages of clinical isolates
compared with environmental isolates of P. aeruginosa [28] and
suggest that within host adaptation could lead to poorer
transmission if bacteria released to external environments are
exposed to natural microbial enemies before infecting new hosts.
From a more applied perspective, phage therapy - the use of
viruses to specifically kill only the disease-causing bacteria - could
be particularly effective against more phage susceptible bacteria
from chronic P. aeruginosa lung infections that cannot anymore be
eradicated with antibiotics.
Materials and Methods
Ethics statement
The present project is in compliance with the Helsinki
Declaration (Ethical Principles for Medical Research Involving
Human Subjects). Strains were collected from sputum as part of
the patients’ routine care, without any additional sampling. The
ethic committee in ‘‘RegionH The Capital Region of Denmark’’
was consulted, specifically approved this study and declared that
patient informed consent was not needed.
Study species and culture conditions
A total of 28 different P. aeruginosa isolates, two different protist
strains (T. thermophila and A. polyphaga) and 4 different phage species
(14/1, WKZ, PNM and PT7) were used in the experiments (strains
listed in Tables 1 and 2). All phage and protist species used in this
study are commonly found in natural environments [29–31],
where they likely cause high bacterial mortality and hence strong
selection for resistance [28,32]. Bacterial strains were obtained
from Copenhagen CF Center Rigshospitalet (partly described
earlier [33]) and divided into two categories on the basis of
following guidelines [27]: bacterial strains isolated from relatively
young, intermittent colonisations, that can be eradicated with
antibiotics while no antibodies are yet found from patient serum,
and bacteria isolated from chronic infections, where pathogens are
continuously discovered from sputum samples for .6 months
and/or there is a significant antibody response against P. aeruginosa
[27].
Bacterial stocks were prepared by growing bacteria overnight on
KB agar plates, after bacterial mass was streaked and mixed to M9
salt solution with sterile loops (VWR). All clones were diluted to
the same densities (approximately 0.2 optical density at 600 nm
wavelength, equalling approximately 9 6 1076150 cells mL21).
Colony colour and morphology of every strain was recorded by
plating bacteria on King’s B (KB) medium agar plates (M9 salt
solution supplemented with 10 g L21 glycerol, 20 g L21 proteose
peptone and 12 g L21 agar). Both protist stocks were cultured with
non-living resource prior the experiments; Peptone Yeast medium
(PPY; 20 g L21 Peptone and 2.5 g L21 of Yeast extract) was used
for T. thermophila and Proteose Peptone Glucose medium (PPG;
Page’s Amoeba Saline solution supplemented with 15 g L21
Peptone and 18 g L21 of D-glucose) for A. polyphaga. Both protist
stock solutions were diluted ten-fold with M9 buffer to obtain
inoculums for growth measurements. Phage stock solutions were
prepared by growing all frozen phages (–80uC) with PAO1 (ATCC
#15692) strain in liquid KB medium for 24h before chloroforming
(10% volume) and centrifugation to purify phages from bacteria.
Phages were stored at 4uC. Phage densities were estimated by
diluting and plating three independent stock solutions of each
phage species onto lawns of PAO1 bacterial strain. The mean
6s.e. density (PFU, i.e., plaque forming units) for each phage
species was as follows: 14/1: 591,666,666617638342; WKZ:
305,000,000694,648,472; PNM: 205,000,000671,821,538; PT7:
1,065,000,0006150,582,203. All species were always grown at
28uC.
Bacterial growth measurements in the absence and
presence of phage and protist enemies
The growth of all bacterial strains (starting densities of
approximately 105 cells mL21; see methodology for equalizing
inoculum above) was measured both in the absence and presence
of every single enemy in 200 mL of fresh 10% KB medium by
using a photo spectrometer (Bio-Tek Instruments, Inc.,Winooski,
VT, USA, OD 600 nm). In the enemy-cocultures, small inoculums
of every enemy were subsequently added to microplate wells
immediately after inoculating bacteria: 20–25 cells of A. polyphaga,
10–15 cells of T. thermophila, 591666 particles of 14/1 phage,
305000 particles of WKZ phage, 205000 particles of PNM phage
and 1065000 particles of PT7 phage. All growth measurements
were replicated twice and run for 91 hours.
Bacterial life-history trait measurements
We determined the resistance to phages by streaking indepen-
dent bacterial clones across a line of each phage (40 mL) that had
Within-Host Specialization and Enemy Resistance
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Table 1. Bacterial strains used in this study.
Strain No. Patient No. Source Year obtained Infection type Duration of infection Colony type
1 1 Copenhagen CF Center Rigshospitalet 2004 Intermittent
colonisation
6 months Yellow
2 2 Copenhagen CF Center Rigshospitalet 2005 Intermittent
colonisation
6 months Yellow
3 2 Copenhagen CF Center Rigshospitalet 2006 Intermittent
colonisation
12 months Yellow
4 2 Copenhagen CF Center Rigshospitalet 2006 Intermittent
colonisation
25 months Yellow
5 3 Copenhagen CF Center Rigshospitalet 2005 Intermittent
colonisation
16 months Yellow
6 3 Copenhagen CF Center Rigshospitalet 2006 Intermittent
colonisation
22 months Yellow
7 4 Copenhagen CF Center Rigshospitalet 2005 Intermittent
colonisation
1 month Yellow
8 5 Copenhagen CF Center Rigshospitalet 2004 Intermittent
colonisation
4 months Yellow
9 6 Copenhagen CF Center Rigshospitalet 2007 Intermittent
colonisation
4 months White
10 7 Copenhagen CF Center Rigshospitalet 2006 Intermittent
colonisation
, 1 month Yellow
11 8 Copenhagen CF Center Rigshospitalet 1978 Chronic infection 2 years Yellow
12 8 Copenhagen CF Center Rigshospitalet 1985 Chronic infection 9 years Yellow
13 8 Copenhagen CF Center Rigshospitalet 1987 Chronic infection 11 years Yellow
14 8 Copenhagen CF Center Rigshospitalet 1991 Chronic infection 15 years White
15 9 Copenhagen CF Center Rigshospitalet 1984 Chronic infection 1 year Yellow
16 9 Copenhagen CF Center Rigshospitalet 1988 Chronic infection 5 years White
17 9 Copenhagen CF Center Rigshospitalet 2004 Chronic infection 21 years White
18 10 Copenhagen CF Center Rigshospitalet 1997 Chronic infection 4 years White
19 10 Copenhagen CF Center Rigshospitalet 1999 Chronic infection 6 years Yellow
20 10 Copenhagen CF Center Rigshospitalet 2004 Chronic infection 11 years White
21 11 Copenhagen CF Center Rigshospitalet 1979 Chronic infection 3 years Yellow
22 11 Copenhagen CF Center Rigshospitalet 1984 Chronic infection 8 years Yellow
23 11 Copenhagen CF Center Rigshospitalet 1985 Chronic infection 9 years Yellow
24 11 Copenhagen CF Center Rigshospitalet 1994 Chronic infection 18 years White
25 11 Copenhagen CF Center Rigshospitalet 1999 Chronic infection 23 years White
26 12 Copenhagen CF Center Rigshospitalet 1991 Chronic infection 1 year White
27 13 Copenhagen CF Center Rigshospitalet 1986 Chronic infection 6 years White
28 13 Copenhagen CF Center Rigshospitalet 2002 Chronic infection 22 years White
doi:10.1371/journal.pone.0075380.t001
Table 2. Protist and phage species used in this study.
Strain Enemy type Source Family
Tetrahymena thermophila, CCAP 1630/1U Ciliate protist Unknown, Claff (1939) Tetrahymenidae
Acanthamoeba polyphaga, CCAP 1501/18 Amoeba protist Unknown, Rowbotham (1985) Amoebadie
14/1 Phage Sewage water, Regensburg, Germany, 2000 Myoviridae A1
WKZ Phage Sewage water, Kazakhstan, 1975 Myoviridae A1
PNM Phage Mtkvari River, Tbilisi, Georgia, 1999 Podoviridae C1
PT7 Phage Lake Ku, Tibilisi, Georgia, 1999 Myoviridae A1
doi:10.1371/journal.pone.0075380.t002
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previously streaked and dried on a KB agar plate. A colony was
scored as resistant if there was no inhibition of growth by the
phage [34].
Bacterial biofilm was measured by growing all clones for 48 h in
10% KB, after, 50 ml of 1% crystal violet solution was added to the
microplate wells and rinsed off with distilled water after
10 minutes. The remaining crystal-violet attached to bacteria
was dissolved in 96% ethanol and the amount of biofilm formed
measured as OD at 600 nm [35].
Motility was assessed by sticking a trace inoculum (,2 mL) of
each clone with a sterile loop (VWR) to the centre of a semi-solid
agar plate (as described above, except 0.7% agar). The plates were
photographed after 48h and the colonised area was determined
with ImagePro Plus 4.5 software (Media Cybernetics).
Protease expression was measured as a zone of hydrolysis on KB
agar plates incremented with 20 g L21 of skim milk powder
(Merck). Bacteria were first grown in 10% KB for 48 h, before
inserting 10 mL of solution on sterilised filter disk ( 6 mm,
Whatman). Protease expression was determined as a zone of
hydrolysis after 24h incubation.
Bacterial virulence was measured in wax moth larvae (Galleria
mellonella, Lepidoptera; Pyralidae; Livefood UK). Bacterial viru-
lence measured in G. mellonella, mammals and mammalian cell
cultures have been found to correlate positively, making it an ideal
model host for general virulence testing [36,37]. All larvae were
weighed before infection to achieve equal mean weights between
treatments (bacterial group: F4, 331 = 1.5, P=0.19). Eight larvae
per clone were injected with 30 mL (on average 361056150 CFU)
of bacterial solution between the abdominal segments 6 and 7 with
a 1 mL Terumo syringe. Sixteen larvae were injected with 30 mL
of M9 buffer to control the damage caused by the injection itself.
After infection, larvae were placed on individual wells of 24-well
cell culture plates and survival monitored at 2-hour intervals for 3
days at 28uC. Larvae were defined as dead when they did not
respond to touch with forceps. Larvae that were still alive after 5
days from infection were given time-to-death value of 141 hours.
Statistical analyses
A General linear mixed model (GLMM) was used to analyse
differences in bacterial growth in the absence and presence of
protists and phage enemies. Because some patients had been
sampled at repeatedly different time points, patient mean values
were used. We first compared the means of patients suffering from
intermittent colonisation or chronic infection. Second, we analysed
the effect of infection duration by comparing chronic patients with
infection lasting either under or over ten years. Lastly, we analysed
the significance of bacterial colony type (yellow or white) of
chronic patients that had both colony types present (patients no 8–
11; Table 1). In these models, bacterial growth was explained with
infection type (intermittent vs. chronic), enemy type (no enemy,
phage, amoeba, ciliate), time, and additionally, with the length of
chronic infection (,10 and .10 years) or colony type (yellow or
white). When needed, additional GLMMs were carried out to
compare the effect of phage species. In all growth data analyses,
populations were used as a subject variables, time as a repeated
factor (5 levels; 16, 24, 48, 72 and 91 hours) and patient identity
included in the models as a random factor (nested infection type).
Phage resistance was analysed with ANOVA where arcsin
transformed patient mean resistances were explained by infection
type and phage species. Bacterial motility, biofilm formation,
protease expression and virulence were analysed with indepen-
dent-samples T-tests. Non-parametric Mann-Whitney test was
used to analyse bacterial ability to kill protists.
Results
Bacterial defence against different enemies
Bacterial growth was affected by the infection type
(F1, 58.2 = 63.8, P,0.001) and the presence and type of enemy
(F3, 87.7 = 17.6, P,0.001, Figure 1a-b): chronic bacterial isolates
grew generally slower (P,0.001), and while the ciliate T.
thermophila clearly reduced bacterial densities regardless of the
infection type (P,0.001), A. polyphaga amoeba and phages had no
effect on bacterial densities (P=0.84 and P=0.099, respectively).
There was a significant interaction between enemy type and
infection type: phages reduced the densities of bacteria isolated
from chronic infection regardless of the phage species (infection
type6 enemy type: F3, 87.7 = 7.7, P,0.001; pairwise comparison:
P=0.04; phage species: F3, 15.6 = 0.37, P=77, Figure 1a-b), while
phages had no effect on bacteria associated with intermittent
colonisation (pairwise comparison: P=0.59). To further explore
this, we next compared chronic patients that had been sampled
repeatedly in time, and asked if bacterial growth in the absence
and presence of enemies differ between samples isolated from less
than ten year long and over ten year long chronic infections. We
found similar main effect for the enemy type as above
(F3, 52.4 = 1557, P,0.001): amoebae had no effect on bacterial
densities (P=0.81), while both ciliates and phages decreased
bacterial densities (P,0.001 and P,0.001, respectively; data not
shown). However, the effect of time on bacterial growth was non-
significant (F1, 13.7 = 0.42, P=0.52) regardless of the enemy
community type (infection length 6 enemy type: F3, 52.4 = 0.21,
P=0.889; data not shown), suggesting that the duration of chronic
infection does not significantly alter bacterial resistance against
ciliate and phage enemies.
Interestingly, we found that 90% of intermittent bacterial
isolates formed yellow colonies similar to P. aeruginosa PAO1 strain,
while chronic isolates formed yellow colonies in 44% and white
colonies in 56% of cases (Fisher exact test colony type6 infection
class, P=0.041, Table 1). As a result, we compared if white and
yellow chronic colony types differ in their growth under different
enemies. The enemy communities had similar effects as above
(F3, 50.3 = 4.7, P=0.006): amoebae had no effect on bacterial
densities (P=0.87), while both ciliate and phages decreased
bacterial densities (P=0.005 and P=0.016, respectively). More-
over, white colonies were poorer at growing (F1, 66.9 = 8.3,
P=0.005), and this difference was also dependent on enemy
community type (colony type 6 enemy type: F3, 66.2 = 2.9,
P=0.04): both ciliates and phages were better at reducing the
densities of white bacterial colony types (F3, 33.2 = 4.3, P=0.01;
Figure S1c-d) compared to yellow colony types (F3, 42.8 = 2.6,
P=0.06), which suggest that the reduced defence to ciliate and
phage enemies was especially attributed to chronic white colony
types which were often observed in the later stages of chronic
infections (Table 1).
The lack of phage effect on the growth of bacteria isolated from
intermittent colonisations can be in part explained by innate phage
resistance: bacterial resistance to phages was generally higher with
intermittent compared to chronic isolates (F1, 40 = 6.2, P=0.017;
Figure 1c) with different phage species having similar effects
(F3, 40 = 0.24, P=0.86). While the duration of infection did not
clearly affect the degree of phage resistance with chronic isolates
(F1, 36 = 3.17, P=0.083; data not shown), the chronic white colony
types were less phage resistant compared to yellow colony types
(F1, 16 = 4.3, P=0.05; mean resistance and 6 1 standard error for
intermittent and chronic patients respectively: 0.32160.094 and
060.079). This suggests that the lowered phage resistance of
Within-Host Specialization and Enemy Resistance
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chronic isolates was due to lower resistance of white colony types
associated with later stages of chronic infections.
The lack of A. polyphaga effect on bacterial densities was likely
due to P. aeruginosa toxicity: all bacterial clones were able to kill A.
polyphaga amoeba (no living cells observed after 91 h cocultivation;
data not shown). In the case of T. thermophila, chronic isolates were
less toxic compared to intermittent CF-lung isolates (Mann-
Whitney U=6, P=0.035, Figure 1d; while no difference in
toxicity was found between ,10 years and .10 years old isolates
(Mann-Whitney U=13, P=0.42; data not shown), or yellow and
white colony types (Mann-Whitney U=11, P=0.5; data not
shown).
In summary, these results suggest that P. aeruginosa clones
isolated from chronic CF-lungs grow slower and are more
susceptible to phages and ciliates compared to bacteria isolated
from intermittently colonised CF-lungs.
Bacterial virulence trait measurements
Adaptation to the lung environment decreased bacterial
virulence, i.e., there was increased larval survival associated with
Figure 1. Bacterial growth in the absence and presence of different enemies. The growth of bacteria isolated from patients with
intermittent colonisation (a) or chronic (b) CF-lung infection; panels show mean values averaged over time (91 hours). Panels (c) and (d) show
bacterial phage resistance (c) and ability to kill ciliate protist (d) for patients suffering from intermittent colonisation or chronic CF-lung infection. Error
bars denote 6 1 SEM.
doi:10.1371/journal.pone.0075380.g001
Within-Host Specialization and Enemy Resistance
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chronic infection versus intermittent colonisation (infection type:
P=0.001, t = –4.5, df = 10; Figure 2a). However, no difference
was found between ,10 years and .10 years old chronic isolates
(P=0.3, t = –1.0, df = 9), or between white and yellow chronic
isolates (P=0.26, t = –1.2, df = 6; data not shown). Also, no
difference in motility or biofilm formation was found between
intermittent and chronic isolates (P=0.21, t = 1.3, df = 10 and
P=0.56, t = 0.58, df = 10, respectively, Figure 2b-c), ,10 years
and .10 years old chronic isolates (P=0.33, t = –1, df = 9 and
P=0.92, t = –0.9, df = 9, respectively), or white and yellow chronic
isolates (P=0.4, t = –0.89, df = 6 and P=0.83, t = 0.22, df = 6,
respectively; data not shown). However, bacterial protease activity
was clearly higher with more virulent, intermittent isolates
(P=0.003, t = 3.9, df = 10; Figure 2b), while ,10 years and
.10 years old chronic isolates (P=0.97, t = 0.03, df = 9), and
white and yellow chronic isolates (P=0.39, t = –0.9, df = 6) had
equally high protease expression (data not shown). These results
show that within-host specialisation leads to lowered virulence,
which could be mechanistically explained by lowered protease
expression.
Discussion
Here we studied how P. aeruginosa adaptation to the lungs of CF
patients affects its fitness in external environments. We found that P.
aeruginosa bacteria isolated from chronic CF-lung infections were less
efficient at killing protists and had lower resistance against phages
compared to bacteria isolated from intermittent CF-lung colonisa-
tions. This difference was partly explained by the high frequency of
small, smooth colony variants in chronic infections, which showed
poor growth in liquid medium and were especially susceptible to
phages. The chronic isolates’ increased susceptibility to ciliate and
phage enemies also correlated with lowered virulence in the insect
host. However, the duration of chronic infection (,10 vs..10 years)
had minor effects on bacterial fitness, suggesting that prolonged
selection within host did not further shape bacterial virulence or
resistance to natural enemies. Together these results suggest that P.
aeruginosa transition from intermittent colonisation to chronic CF-
lung infection leads to fitness costs in external environment
potentially leading to poorer environmental transmission.
That long-term chronic infection in CF-lung environment was
associated with greatly reduced resistance to phages was somewhat
surprising, given that adaption to the CF-lung is associated with
loss and alteration of range of potential phage receptors [8,38],
which could potentially lead to higher phage resistance. We
suggest three possible reasons for our findings. First, phage-
imposed selection might be stronger during intermittent colonisa-
tions resulting in relatively higher phage resistance. While it has
been reported that phages are found in CF-lungs [39,40], these
studies are often based on purely on detection of phage, e.g. by
electron microscopy [39] or sequencing [40], and tell little about
the densities and biological activity of bacteriophages in CF-lungs.
For example, chronic CF-lungs could be dominated by lysogenic
prophages that reside most of the time within bacterial genomes
and only occasionally induce lytic infection of bacterial cells [41];
in this case, phages might have a relatively small role in regulating
bacterial densities despite their prevalence. Second, resistance
mutations are often associated with costs [42], and these costs
could be increased if chronic infections experience more stressful
environments than intermittent colonisations, even if phage-
imposed selection is comparable [43]. Finally, selection for phage
resistance may be reduced, or actively selected against, in both
intermittent colonisation and chronic infections, but loss of
resistance (through selection or even drift, if phage resistance is
selectively neutral) has occurred to a greater extent in he chronic
infections. Consistent with this view, a recent study reported that
clinical P. aeruginosa isolates have generally lower phage resistance
compared to environmental P. aeruginosa isolates [28]; In other
words, it is possible that phages select for high resistance in
environmental reservoirs [44], while the resistance is lost during
chronic bacterial infections in the absence of phage selection.
Bacteria isolated from chronic infections were generally less
effective at killing T. thermophila ciliates (although, surprisingly,
ciliates reduced density of both types of infections to the same
extent), while both intermittent and chronic isolates were deadly
for A. amoebae. The chronic CF isolates’ reduced ability to kill
ciliates could be explained by reduced production of toxic exo-
factors. It has been shown previously that adaptation to CF-lungs
reduces rhamnolipid and elastase expression [45], while quorum-
sensing deficient mutants typically observed in CF-lungs are less
toxic for nematodes [26], Rhynchomonas nasuta protists [46] and T.
pyriformis (Friman et al. [In press]). In support, we found that the
protease expression of chronic isolates was clearly reduced
compared to bacteria isolated from intermittent colonisations. As
for phage resistance, protease expression (and toxicity to protists in
general) could be lost during chronic infections simply because it is
costly having negative effect on bacterial growth [47], because it
provokes stronger immune responses towards the pathogen [48],
or is selectively neutral and is lost through drift. In contrast to T.
thermophila, A. polyphaga amoebae were killed in all bacterial co-
cultures regardless of the type of infection probably because they
were more sensitive to bacterial toxins or because bacteria were
simply able to overgrow them in relatively rich nutrient medium.
The rise of small and white P. aeruginosa colony types is often
connected to enhanced persistence and survival during long-term
cystic fibrosis infections [8,49]. We found that both phages and
ciliates were more efficient in reducing the densities of white
colony type. Which made this colony type especially vulnerable?
One explanation for lowered resistance to ciliates could lie in
reduced growth and toxicity. Furthermore, even though yellow
and white colony types did not differ in in mean motility or biofilm
formation, it is still possible that for example the biofilm structure
or the number of pili differed between these colony types. While
these both traits has been connected to changes in both P.
aeruginosa phage resistance and colony morphology [50], further
tests are11 needed to confirm this.
Consistent with previous work [12], adaptation to CF-lung
environment also led to reduction in bacterial virulence in wax
moth hosts. The loss of virulence was connected to chronic isolates
that were poor at growing and expressed weakly proteases, while
no clear changes in biofilm formation or motility was observed
(lack of effect on motility probably due to pooling of different aged
bacterial isolates to patient means for analysis). Whether slow
growth and reduced virulence is itself adaptive in terms of helping
bacterial cells to go unnoticed by host immune system [51] or
resist antimicrobial chemotherapy [52], or if it is a pleiotropic cost
associated with other within-host adaptation is unclear.
The observed loss of phage resistance is encouraging in relation
to phage therapy: the use of viruses to specifically kill only the
disease-causing bacteria [53–55]. First, bacterial isolates from
chronic infections were especially sensitive to phages. Second,
chronic bacterial isolates had poor growth and small population
sizes, which will make the emergence of beneficial resistance
mutations less likely. Third, if adaptive changes behind within-host
adaptation are due to loss of genetic material [56], bacteria might
not be able to reverse evolution without horizontal gene transfer.
As a result, phage therapy could prove especially effective against
chronic bacterial infections that cannot anymore be eradicated
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with antibiotics. Even though potential complications might rise
from the spatial distribution and within- and between-species
diversity of bacterial infections [57–59], identifying similar fitness
trade-offs for bacterial survival between natural and clinical
environments could serve as a starting point for developing
potential alternatives for antibiotics. For example, within-host
specialization could make bacteria more susceptible to bacterium-
specific toxins (bacteriocins) that are used in intraspecific bacterial
competition in natural environments [47,60], but might not be
needed in the lungs of CF patients.
To conclude, our study shows that environmentally transmitted
pathogens’ long-term adaptation to a within-host environment is
associated with reduced defence against natural phage and protist
enemies. This result supports the general idea that more
permanent association with host organisms leads to loss of
pathogen virulence, which might play a key role in explaining
evolutionary transitions from antagonistic interactions towards
commensalisms and mutualism. Moreover, even though the effect
of protist predation on bacterial virulence evolution has been
studied quite extensively [14–18,20], the consequences of within-
host adaptation for opportunistic pathogens’ survival, transmission
and prevalence in environmental reservoirs are still poorly
understood. For example, from the epidemiological point of view,
chronically infected patients could be seen as pathogen ‘‘sinks’’
because their further spread and transmission through environ-
ment is limited by their reduced survival in the presence of natural
microbial enemies. In the future more effort should thus be put on
trying to understand the connectedness and selection in clinical
Figure 2. Bacterial trait measurements. Bacterial virulence measured in vivo for patients with intermittent colonisation or chronic CF-lung
infection (a): virulence is defined as less hours to larval death, more virulent the bacterial strain. Panel (b) shows difference in bacterial protease
expression, panel (c) difference in biofilm formation and panel (d) difference in motility for patients suffering from intermittent colonisation or chronic
CF-lung infection. Error bars denote 6 1 SEM.
doi:10.1371/journal.pone.0075380.g002
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and environmental compartments and how they jointly define the
evolution of pathogen virulence [19].
Supporting Information
Figure S1 Bacterial growth in the absence and presence
of different enemies. The growth of bacteria isolated from
patients with intermittent colonisation (a) or chronic (b) CF-lung
infection. Panels (c) and (d) show bacterial growth in the absence
and presence of different enemies for yellow (c) and white (d) colony
type means for chronic CF-patients. Error bars denote 6 1 SEM.
(TIF)
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